These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8729880)

  • 21. Comparison of an antibody model with an X-ray structure: the variable fragment of BR96.
    Bajorath J; Sheriff S
    Proteins; 1996 Feb; 24(2):152-7. PubMed ID: 8820482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FlexE: efficient molecular docking considering protein structure variations.
    Claussen H; Buning C; Rarey M; Lengauer T
    J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody modelling. Tackling a loopy problem.
    Thornton JM
    Nature; 1990 Feb; 343(6257):411-2. PubMed ID: 2300188
    [No Abstract]   [Full Text] [Related]  

  • 24. ABGEN: a knowledge-based automated approach for antibody structure modeling.
    Mandal C; Kingery BD; Anchin JM; Subramaniam S; Linthicum DS
    Nat Biotechnol; 1996 Mar; 14(3):323-8. PubMed ID: 9630894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The structure of an antitumor C(H)2-domain-deleted humanized antibody.
    Larson SB; Day JS; Glaser S; Braslawsky G; McPherson A
    J Mol Biol; 2005 May; 348(5):1177-90. PubMed ID: 15854653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational analysis of the first observed non-proline cis-peptide bond occurring within the complementarity determining region (CDR) of an antibody.
    Bates PA; Dokurno P; Freemont PS; Sternberg MJ
    J Mol Biol; 1998 Dec; 284(3):549-55. PubMed ID: 9826497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of protein structures reveals regions of rare backbone conformation at functional sites.
    Petock JM; Torshin IY; Weber IT; Harrison RW
    Proteins; 2003 Dec; 53(4):872-9. PubMed ID: 14635129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular dynamics simulation of a high-affinity antibody-protein complex: the binding site is a mosaic of locally flexible and preorganized rigid regions.
    Sinha N; Smith-Gill SJ
    Cell Biochem Biophys; 2005; 43(2):253-73. PubMed ID: 16049350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody therapeutics, antibody engineering, and the merits of protein stability.
    Demarest SJ; Glaser SM
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of the single crystal X-ray determination and molecular modelling of the binding of oligomycin to ATP synthase.
    Green RC; Thumser AE; Povey D; Saldanha JW; Potter BS; Palmer RA; Howlin BJ
    Comput Biol Chem; 2009 Jun; 33(3):189-95. PubMed ID: 19217349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural model of the anti-snake-toxin antibody, M alpha 2,3.
    Tenette C; Ducancel F; Smith JC
    Proteins; 1996 Sep; 26(1):9-31. PubMed ID: 8880926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling bound ligands in protein crystal structures.
    Zwart PH; Langer GG; Lamzin VS
    Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 1):2230-9. PubMed ID: 15572776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The structure of an antibody molecule.
    Cancer J Sci Am; 1995; 1(1):83. PubMed ID: 16998974
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular forces in antibody maturation.
    Demirel MC; Lesk AM
    Phys Rev Lett; 2005 Nov; 95(20):208106. PubMed ID: 16384106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T; Elcock AH
    J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potentials of conditional optimization in phasing and model building of protein crystal structures.
    Scheres SH; Gros P
    Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 1):2202-9. PubMed ID: 15572773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dual-scale approach toward structure prediction of retinal proteins.
    Chen CC; Chen CM
    J Struct Biol; 2009 Jan; 165(1):37-46. PubMed ID: 19000929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structure of a cocaine-binding antibody.
    Larsen NA; Zhou B; Heine A; Wirsching P; Janda KD; Wilson IA
    J Mol Biol; 2001 Aug; 311(1):9-15. PubMed ID: 11469854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular recognition of a peptide mimic of the Lewis Y antigen by an anti-Lewis Y antibody.
    Murali R; Kieber-Emmons T
    J Mol Recognit; 1997; 10(6):269-76. PubMed ID: 9770651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes.
    Minor W; Cymborowski M; Otwinowski Z; Chruszcz M
    Acta Crystallogr D Biol Crystallogr; 2006 Aug; 62(Pt 8):859-66. PubMed ID: 16855301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.